bnail","description":"$23"}],"format":{"id":1,"name":"In-person Conference/Meeting","image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/7ff9f3e2-08d5-43f1-d325-9f82f4291a00","created_at":"2025-08-04T20:27:06.754953+00:00","description":""},"country":"","faculty":[{"id":null,"user":{"id":null,"dob":null,"city":null,"email":null,"state":null,"prefix":null,"street":null,"country":null,"zipcode":null,"last_name":null,"disclosure":[],"first_name":null,"middle_name":null,"affiliations":[],"designations":[],"phone_number":null,"profile_picture":null,"has_financial_relation":null},"conf_role":null,"is_published":null}],"zipcode":"","end_date":"2026-10-24T07:00:00+00:00","isActive":true,"latitude":0,"location":"","seo_json":null,"conf_lead":27,"longitude":0,"categories":[{"id":117,"category":{"id":12,"image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/88c164ce-74c9-45dd-77a3-56100fb49300","title":"Hematology","description":""}}],"clone_json":null,"created_at":"2026-06-17T21:14:24.536416+00:00","flyer_link":null,"image_name":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/c044ce5d-bd88-4c45-0ce5-94f30cc04c00/thumbnail","meta_title":"","start_date":"2026-10-24T07:00:00+00:00","updated_at":null,"description":"$24","is_cfp_conf":false,"is_published":true,"schema_image":null,"slug_history":[],"accreditations":null,"additional_tax":null,"exhibitor_link":null,"homepage_image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/c044ce5d-bd88-4c45-0ce5-94f30cc04c00/thumbnail","additional_info":"","target_audience":"

Hematology/Oncology physicians
Hematopathologists
Advanced practice providers
Oncology pharmacists
Oncology Nurses

","meta_description":"","calculated_credit":null,"learning_objectives":"

At the conclusion of this activity, participants should be able to:

Apply current diagnostic criteria, molecular profiling techniques, and pathologic classifications to diagnose and risk-stratify patients with rare hematologic malignancies accurately.
Evaluate emerging clinical evidence supporting the use of targeted therapies, immunotherapies, and cellular therapies for the treatment of rare hematologic malignancies.
Develop evidence-based, multidisciplinary treatment plans that incorporate current guidelines, clinical trial opportunities, and individualized patient factors.
Implement strategies for monitoring and managing disease-related complications and treatment-associated toxicities to improve patient outcomes and quality of life.

","abstract_description":"","has_default_donation":true,"organizing_committee":"

Conference Director:

Binay Shah, MD, MHA - Binaytara

Conference Chair:

Vinod Pullarkat, MD - City of Hope

","price_additional_info":null,"accreditation_additonal_info":null,"conf_lead_user":{"id":27,"first_name":"Bhawana","last_name":"Srivastava","email":"bhawana.s@binaytara.org","profile_picture":null,"prefix":"Dr."}},"programData":[],"globaldata":{"id":17,"title":"Global","description":"This is global page.","createdAt":"2024-07-23T00:38:43.957Z","updatedAt":"2026-06-19T08:19:17.861Z","publishedAt":"2024-07-23T00:39:07.474Z","jsonld":null,"header":{"id":17,"logoText":{"id":217,"url":"/","text":"Binaytara","isExternal":false},"ctaButton":{"id":218,"url":"https://give.binaytara.org/campaign/603477/donate?utm_source=button&utm_medium=landing_page&utm_campaign=donate&utm_content=global&c_src

About 2026 Rare Hematology, LA

Overview

Registration and pricing